Cyclerion Therapeutics CYCN
NASDAQ CYCN
$3.89 -0.18 (-4.42%)
As of: Aug 21, 2026 · 3:59 PM EDT

Cyclerion Therapeutics (CYCN) EPS (Basic) Growth (5y) (2023 - 2025)

Cyclerion Therapeutics (CYCN) EPS (Basic) Growth (5y) (2023 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn -
10 Cyclerion Therapeutics 12.71 Mn 9.47 Mn -

Historic Data

Download Data
DateValue
Sep 30, 2025 53.69%
Jun 30, 2025 47.86%
Mar 31, 2025 87.17%
Sep 30, 2023 14.87%
Jun 30, 2023 86.35%